Loading...
XSHG
600521
Market cap3.79bUSD
Dec 05, Last price  
17.98CNY
1D
1.24%
1Q
-33.23%
Jan 2017
-2.07%
IPO
89.66%
Name

Zhejiang Huahai Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:600521 chart
P/E
23.94
P/S
2.81
EPS
0.75
Div Yield, %
1.11%
Shrs. gr., 5y
-0.02%
Rev. gr., 5y
12.12%
Revenues
9.55b
+14.91%
423,245,597557,259,616706,981,032801,432,207927,967,0131,022,844,6511,827,614,0152,014,390,9672,296,407,7122,584,987,5663,500,362,0974,092,852,9615,002,002,7175,094,596,2215,388,094,5926,485,213,4176,643,573,1438,265,744,7938,308,719,7589,547,425,412
Net income
1.12b
+34.74%
128,912,937110,013,773132,026,144150,066,497164,978,38793,586,510216,905,530341,123,050359,168,439265,500,660442,472,433500,831,356639,246,679107,514,561569,595,139929,815,152487,535,1171,167,758,749830,466,0031,118,981,177
CFO
2.17b
-2.00%
53,300,72077,542,440136,522,12484,203,195317,436,771299,471,572197,514,841243,829,247490,293,727328,608,722195,314,063433,099,734546,240,88567,895,8401,753,946,2181,555,458,119938,429,8301,242,693,1262,217,021,2742,172,663,923
Dividend
Jul 10, 20240.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps. In addition, the company provides contract manufacturing and other services. Further, it is involved in import and export trade services. Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.
IPO date
Mar 04, 2003
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT